2017-2018 Funded Collaborations
International Collaborative Grants
Macrophages-shuttling of miRNA Via Exosomes Reprograms Glucose Metabolism in Pancreatic
|
|
|
Mei Kong, Ph.D.
Cancer Biology
City of Hope
|
Ziv Gil, M.D., Ph.D.
Rambam Health Care Campus
Laboratory for Applied Cancer Research
|
Modifying the prey: Targeting of signal regulators with siRNA for improved viral oncolysis
|
|
|
Marcin Kortylewski, Ph.D.
Immuno-oncology
City of Hope
|
Marcelo Ehrlich, Ph.D.
Tel Aviv University
Cell Research and Immunology
|
Metallocorroles for imaging and therapy in malignant melanoma
|
|
|
John Termini, Ph.D.
Molecular Medicine
City of Hope
|
Zeev Gross, Ph.D.
Technion, Israel Institute of Technology
Schulich Faculty of Chemistry
|
Sabbatical
Theranostic Metallodrugs for Imaging and Fighting Cancer
|
|
|
|
John Termini, Ph.D.
Molecular Medicine
City of Hope
|
Zeev Gross, Ph.D.
Technion, Israel Institute of Technology
Schulich Faculty of Chemistry
|
About the Israel Cancer Research Fund
Israel Cancer Research Fund, a 501(c)(3) organization, is the largest nationwide charitable organization in North America solely devoted to supporting cancer research in Israel. Since its establishment in 1975, ICRF has provided more than 2,200 grants to outstanding cancer researchers whose laboratories are located in all of the leading research institutions, universities and hospitals across Israel. For more information, visit www.icrfonline.org.